Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Psychobiotics and Trace Elements in Neurodegenerative Diseases: From Independent Modulators to Potential Interactions Within the Microbiota–Gut–Brain Axis—Narrative Review

  1. 1Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Bialystok, Poland

Abstract

The microbiota–gut–brain axis represents an important bidirectional communication network linking the gastrointestinal tract and the central nervous system and may contribute to processes involved in neurodegeneration. Increasing attention has been directed toward psychobiotics as potential modulators of the microbiota–gut–brain axis, while accumulating evidence also indicates that disturbed trace-element homeostasis may contribute to the pathogenesis of neurodegenerative diseases. This review summarizes current evidence on the roles of psychobiotics and trace elements and examines their potential interplay within the microbiota–gut–brain axis. The review discusses bidirectional interactions between the gut microbiota and trace elements, the potential effects of psychobiotic interventions on trace-element homeostasis, and the possible implications of these interactions for neurodegenerative processes. Taken together, current findings indicate that the gut microbiota, psychobiotics, and trace elements may constitute an interconnected system influencing intestinal and systemic homeostasis as well as biological processes relevant to nervous system function. However, direct evidence demonstrating the clinical relevance of interactions between these components remains limited. Moreover, available evidence is largely based on experimental studies, while clinical findings remain scarce and heterogeneous. Further characterization of this interplay may improve our understanding of mechanisms underlying neurodegeneration and provide a basis for the development of more targeted and personalized approaches to supporting neurological health.

Related

  1. Natural Compounds and Their Microbiota-Derived Metabolites as Modulators of the Microbiota–Gut–Brain Axis in Alzheimer Disease: Biochemical Mechanisms and Drug Discovery Insights—A Narrative Review
    Maria Maddalena Cavalluzzi, Francesco Terlizzi, Alessia Catalano +4
    MoleculesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  2. Structure-based virtual screening reveals new metabolite interactions and modulators of human glucose-6-phosphate isomerase
    Y. Y. Jonatansdottir, K. Teigen, J. G. Hjorleifsson
    bioRxivPreprintCC BY-NC-NDFull textGeneral biochemistrybioRxiv
  3. Gut Microbiota, Inflammatory Bowel Disease and the Prioritization of Host Effector Genes: A Two-Sample Mendelian Randomization Study with Independent Replication, cis-eQTL Colocalization and Single-Cell Localization.
    Qiyuan Zou, Jianyi Wang
    International journal of molecular sciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  4. From high-salt diet to cancer immunity: gut microbiota and immune system interactions and their mechanisms
    Jiayu Dong, Liyong Zhou
    Frontiers in immunologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  5. Viral-Gut Microbiota Interactions: Implications for the Gut Mucosa in Inflammatory Bowel Disease.
    Yonghong Wu, Lei Hou, Yue Li +5
    International journal of molecular sciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{sokolska2026psychobiotics,
  title = {{Psychobiotics and Trace Elements in Neurodegenerative Diseases: From Independent Modulators to Potential Interactions Within the Microbiota–Gut–Brain Axis—Narrative Review}},
  author = {Weronika Sokólska and Karolina Orywal},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms27219955},
  url = {https://www.mdpi.com/1422-0067/27/21/9955},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Psychobiotics and Trace Elements in Neurodegenerative Diseases: From Independent Modulators to Potential Interactions Within the Microbiota–Gut–Brain Axis—Narrative Review
AU  - Weronika Sokólska
AU  - Karolina Orywal
PY  - 2026
DA  - 2026/11/06
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27219955
UR  - https://www.mdpi.com/1422-0067/27/21/9955
AB  - The microbiota–gut–brain axis represents an important bidirectional communication network linking the gastrointestinal tract and the central nervous system and may contribute to processes involved in neurodegeneration. Increasing attention has been directed toward psychobiotics as potential modulators of the microbiota–gut–brain axis, while accumulating evidence also indicates that disturbed trace-element homeostasis may contribute to the pathogenesis of neurodegenerative diseases. This review summarizes current evidence on the roles of psychobiotics and trace elements and examines their potential interplay within the microbiota–gut–brain axis. The review discusses bidirectional interactions between the gut microbiota and trace elements, the potential effects of psychobiotic interventions on trace-element homeostasis, and the possible implications of these interactions for neurodegenerative processes. Taken together, current findings indicate that the gut microbiota, psychobiotics, and trace elements may constitute an interconnected system influencing intestinal and systemic homeostasis as well as biological processes relevant to nervous system function. However, direct evidence demonstrating the clinical relevance of interactions between these components remains limited. Moreover, available evidence is largely based on experimental studies, while clinical findings remain scarce and heterogeneous. Further characterization of this interplay may improve our understanding of mechanisms underlying neurodegeneration and provide a basis for the development of more targeted and personalized approaches to supporting neurological health.
SN  - 1422-0067
ER  -